We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Confirms Patent Challenge For Aventis' Nasacort AQ
Barr Confirms Patent Challenge For Aventis' Nasacort AQ
May 16, 2006
Barr Pharmaceuticals is challenging Aventis Pharmaceuticals’ patents for nasal allergy spray Nasacort AQ, Barr said May 4.